To assess postprandial muscle protein synthesis rates in older males in response to ingesting a blend of plant protein fortified with free leucine as compared to (gold standard) whey protein and compared to a plant protein blend without additional…
ID
Source
Brief title
Condition
- Muscle disorders
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
4-hour postprandial muscle protein synthesis rates in rest
Secondary outcome
Plasma amino acid concentrations
Plasma glucose/insulin concentrations
Relevant signalling pathways
Gastrointestinal-palatability scores
Background summary
Muscles are built up out of proteins. These proteins consist of little buidling
blocks: Amino acids. Bij consuming sufficient protein in our nutrition, makes
sure our body has enough building blocks to maintain or increase our muscle
mass. Taking into consideration that de world population is growing, it will be
challenging to have suffient supply of animal-derived protein sources.
Plant-derived proteins can be produced on a more sustainable scale and can
therefore contribute to feeding the future world population. Because the
protein quality of plant-derived proteins is not optimal, these are commonly
consumed as mixtures. Adding isolated amino acids is a strategy to further
improve the protein quality.
Study objective
To assess postprandial muscle protein synthesis rates in older males in
response to ingesting a blend of plant protein fortified with free leucine as
compared to (gold standard) whey protein and compared to a plant protein blend
without additional free leucine.
Study design
randomized, parallel-group, double-blind intervention trial.
Intervention
20g protein as whey, plant-blend, or fortified plant-blend
Study burden and risks
The burden and risks associated with participation in this study are low.
Placing the cannulas is comaprable to a bloodprick and can in some cases lead
to a small hematoma. The muscle biopsies are taken by an experienced physician
under local anaesthesia, but in some cases can be painful upto 24h after the
biopsy. This pain is comparable to the soreness after bumping into a table.
Also, there is a risk of some additional bleeding, but this is no major health
risk. We will take in total 18 blood samples (190 mL), which is less than half
of a blood donation and this will normally recover within a month.
Participants will visit the university twice: 1 screening (2h) and 1 test day
(9h), being fasted (no food and drinks, only water) on both occasions from
22:00 pm the evening before. Besides, they will maintain their habitual
dietary- and activity pattern 3days prior to the test day, but refraining from
heavy physical activity and alcohol consumption. They will also record their
acivity pattern and food intake during the 2 days prior to the test day. On the
screening they will fill in a medical questionnaire.
The dexa scna provides valuable data about the body composition, but has a
small radiation burden. This burden is neglegible when compared to the yearly
background radiation.
During the test day blood and muscle samples will be taken and participants
will consume a drink.
There is no direct benefit for the participants, only their contribution to
scientific knowledge, which can be applied in the future. The participants will
get more insight into their body composition.
Universiteitssingel 50
Maastricht 6229ER
NL
Universiteitssingel 50
Maastricht 6229ER
NL
Listed location countries
Age
Inclusion criteria
Male sex
Aged between 60 and 85 y inclusive
BMI between 18.5 and 35 kg/m2
Exclusion criteria
Vegan/vegetarian diet
Intolerant to milk products
Soy allergy
Pea allergy
Participating in a structured (progressive) exercise program
Smoking regularly (i.e. >5 cigarettes/week)
Diagnosed GI tract disorders or diseases
Diagnosed musculoskeletal disorders
Diagnosed metabolic disorders (e.g. diabetes)
Diagnosed with phenylketonuria (PKU)
Uncontrolled hypertension (blood pressure above 160/100 mmHg)
Donated blood 3 months prior to test day
Use of any medications known to affect protein metabolism (i.e.
corticosteroids, non-steroidal anti-inflammatories).
Chronic use of gastric acid suppressing medication
Chronic use of anti-coagulants
Recent (<1 year) participation in amino acid tracer studies
(L-[ring-13C6]-phenylalanine and L-[3,5-2H2]-tyrosine)
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL82127.068.22 |